Current and future use of dipyridamole in patients with COVID-19

Abstract

Current use of dipyridamole in COVID-19 is mainly based on its antithrombotic activity, since there is no robust clinical effectiveness data. The decision to use dipyridamole in COVID-19 should be individualized, considering the experimental nature of this treatment.

Keywords

• коронавирус
• дипиридамол
• covid-19